SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal - Quaterly Results

14 May 2025 Evaluate
The company witnessed a 7.45% growth in the revenue at Rs. 5524.00 millions for the quarter ended March 2025 as compared to Rs. 5141.00 millions during the year-ago period.Net Profit recorded in the quarter ended March 2025 rise to 48.82% to Rs. 503.00  millions  compared to R. 338.00 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 1240.00 millions from 948.00 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5524.00 5141.00 7.45 18598.00 17846.00 4.21 18598.00 17846.00 4.21
Other Income 5.00 5.00 0.00 50.00 25.00 100.00 50.00 25.00 100.00
PBIDT 1240.00 948.00 30.80 3335.00 2694.00 23.79 3335.00 2694.00 23.79
Interest 179.00 153.00 16.99 752.00 564.00 33.33 752.00 564.00 33.33
PBDT 1061.00 795.00 33.46 2583.00 2130.00 21.27 2583.00 2130.00 21.27
Depreciation 377.00 323.00 16.72 1344.00 1176.00 14.29 1344.00 1176.00 14.29
PBT 684.00 472.00 44.92 1239.00 954.00 29.87 1239.00 954.00 29.87
TAX 181.00 134.00 35.07 330.00 259.00 27.41 330.00 259.00 27.41
Deferred Tax 8.00 -26.00 -130.77 30.00 -25.00 -220.00 30.00 -25.00 -220.00
PAT 503.00 338.00 48.82 909.00 695.00 30.79 909.00 695.00 30.79
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 22.45 18.44 21.73 17.93 15.10 18.79 17.93 15.10 18.79

Hikal Share Price

179.30 1.30 (0.73%)
11-Jun-2026 13:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1802.80
Dr. Reddys Lab 1281.30
Cipla 1387.65
Zydus Lifesciences 1104.80
Lupin 2274.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: